Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
Background: Osteosarcoma is the most common primary bone tumor in childhood and adolescence. Carboplatin, a platinum-derived agent, is used as neoadjuvant chemotherapy for pediatric osteosarcoma because of its anti-tumor activity and had low toxicity as compared to cisplatin. Objective: To determine...
Saved in:
Main Authors: | Worawut Choeyprasert, Rungrote Natesirinilkul, Pimlak Charoenkwan, Somjai Sittipreechacharn |
---|---|
格式: | 雜誌 |
出版: |
2018
|
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877637233&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/48213 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Chiang Mai University |
相似書籍
-
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
由: Worawut Choeyprasert, et al.
出版: (2018) -
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
由: Choeyprasert W., et al.
出版: (2014) -
A randomized, open-labeled, prospective controlled study to assess the efficacy of frontline empirical intravenous piperacillin/tazobactam monotherapy in comparison with ceftazidime plus amikacin for febrile neutropenia in pediatric oncology patients
由: Ruchirek Kamonrattana, et al.
出版: (2020) -
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: The role of high-dose methotrexate (HDMTX) in a single institute experience
由: Worawut Choeyprasert, et al.
出版: (2018) -
Adverse effects of imatinib in children with chronic myelogenous leukemia
由: Worawut Choeyprasert, et al.
出版: (2018)